According to Verified Market Research, the global market for such devices is projected to reach 37.4 billion by 2028, growing ...

Apple might disrupt the world of consumer tech once again. The US-based tech giant has reportedly developed a secret app that monitors blood sugar. The company is testing two tools to try and ...

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

Abbott announced today that the FDA said users can wear the FreeStyle Libre 2 and 3 CGMs during common imaging procedures.

Users of the FreeStyle Libre 2 and 3 continuous glucose monitoring systems from Abbott no longer need to remove and discard the devices for imaging procedures, such as X-rays, CT ...

Abbott today released new data highlighting the emotional challenges faced by people living with type 2 diabetes, revealing key motivators to help them manage their ...

The shift towards glucose-sensing technology has heralded a new era in diabetes management, moving from occasional, reactive ...

Tidepool today announced a new data integration with Abbott for the company's FreeStyle Libre continuous glucose monitors ...

is thrilled to announce a new data integration with continuous glucose monitoring (CGM) manufacturer Abbott (NYSE: ABT). A ...

Tidepool, a software company committed to innovations in diabetes management, is thrilled to announce a new data integration partnership with continuous glucose monitoring (CGM) manufacturer Abbott .

In recent years, smartwatches and smart rings have grown increasingly popular, adorning the wrists and fingers of consumers ...

Tidepool collaborates with Abbott for seamless data integration with its FreeStyle Libre portfolio in the U.S., expanding patient choice and streamlining diabetes care workflows. Tidepool, a software ...